Skip to content

NANOVIRICIDES, INC.

NNVC

CIK 0001379006

← back to feed
Revenue (TTM)
$0
Q3 May 2026
Net Income (TTM)
−$8.21M
−14.1% YoY Q3 May 2026
EPS Diluted (TTM)
−$0.44
+10.0% YoY Q3 May 2026
Gross Margin
—
Q3 May 2026
Operating Margin
—
Q3 May 2026
Net Margin
—
Q3 May 2026
Free Cash Flow (TTM)
−$6.58M
Q3 May 2026
Cash
$3.21M
Q3 May 2026
Total Debt
$4.73M
Q3 May 2026
Shares Outstanding
21.65M sh
Q3 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings